These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31444510)

  • 1. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
    Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
    J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of
    Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
    Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Song H; Guja KE; Iagaru A
    Semin Nucl Med; 2021 Jul; 51(4):392-403. PubMed ID: 33455722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performances of F-18 FDG PET or PET/CT for detection of post-transplant lymphoproliferative disorder: a systematic review and meta-analysis.
    Kim DH; Kim SJ
    Nucl Med Commun; 2020 Jun; 41(6):533-539. PubMed ID: 32282633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
    Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
    Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
    Panagiotidis E; Quigley AM; Pencharz D; Ardeshna K; Syed R; Sajjan R; Bomanji J
    Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
    Brown AK; Carapellucci J; Oshrine B; Gomez A; Meoded A; Asante-Korang A
    Clin Transplant; 2023 Sep; 37(9):e15015. PubMed ID: 37237443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ
    Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of
    Wang C; Wang G; Wang W; Kan Y; Zhang M; Yang J
    Quant Imaging Med Surg; 2024 Feb; 14(2):1323-1334. PubMed ID: 38415126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
    Sidell D; Venick RS; Shapiro NL
    Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
    Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
    Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
    Yang J; Zhuang H
    Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
    Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS
    Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
    Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
    Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
    Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
    Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.